Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy

Abstract

Background and study aims Salvage therapy for esophageal cancer following chemo-radiation therapy (CRT) has not been established. We aimed to evaluate endoscopic submucosal dissection (ESD) as a salvage therapy based on histopathological features of lesions.

Patients and methods We compared 10 lesions in eight patients with local residual, recurrent, or metachronous esophageal squamous cell carcinoma treated by ESD after CRT (CRT group) and 59 lesions treated by ESD without CRT (non-CRT group) during the same period.

Results The en bloc resection rate was 100 % while the complete resection rate was 80.0 % in the lesions after CRT, indicating no difference between the CRT and non-CRT groups. Pathological examination showed that fibrosis was more intense in the lamina propria mucosa, muscularis mucosa, and submucosa. The muscularis mucosa was thicker in both non-tumor and tumor sites in the CRT group compared to the non-CRT group. However, severe submucosal fibrosis was observed only in one lesion in the CRT group. The maximum diameter of the submucosal artery was significantly larger in the CRT group (P < 0.001).

Conclusions Compared to the non-CRT group, the lesions in the CRT group were accompanied by fibrosis while the muscularis mucosa were thicker; however, severe fibrosis of the submucosa was rare. It is important to dissect the muscularis mucosa appropriately during ESD, which makes successful dissection of the submucosa possible. Attention should be paid to bleeding from large arteries.

• References

• 1 Nakamura T, Hayashi K, Ota M. et al. Salvage esophagectomy after definitive chemotherapy and radiotherapy for advanced esophageal cancer. Am J Surg 2004; 188: 261-266
• 2 Tachimori Y, Kanamori N, Uemura N. et al. Salvage esophagectomy after high-dose chemotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2009; 137: 49-54
• 3 Nomura M, Oze I, Kodaira T. et al. Comparison between surgery and definitive chemotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis. Int J Clin Oncol 2016; 21: 890-898
• 4 Ishihara R, Yamamoto S, Iishi H. et al. Factors predictive of tumor recurrence and survival after initial complete response of esophageal squamous cell carcinoma to definitive chemoradiotherapy. Int J Radiat Oncol Biol Phys 2010; 76: 123-129
• 5 Kato H, Sato A, Fukuda H. et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 2009; 39: 638-643
• 6 Kato K, Muro K, Minashi K. et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 2011; 81: 684-690
• 7 Stewart BW, Wild CP. World cancer report 2014. Lyon, France: IARC press; 2014
• 8 Braakhuis BJ, Tabor MP, Kummer JA. et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003; 63: 1727-1730
• 9 Murakami Y, Takahashi I, Nishibuchi I. et al. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0). Int J Clin Oncol 2015; 20: 897-904
• 10 Koizumi S, Jin M, Matsuhashi T. et al. Salvage endoscopic submucosal dissection for the esophagus-localized recurrence of esophageal squamous cell cancer after definitive chemoradiotherapy. Gastrointest Endosc 2014; 79: 348-353
• 11 Saito Y, Takisawa H, Suzuki H. et al. Endoscopic submucosal dissection of recurrent or residual superficial esophageal cancer after chemoradiotherapy. Gastrointest Endosc 2008; 67: 355-359
• 12 Ishii N, Suzuki K, Fujita Y. Salvage endoscopic submucosal dissection for recurrent esophageal squamous-cell carcinoma after definitive chemoradiotherapy. Clin 2011; 4: 85-88
• 13 Kurokawa Y, Muto M, Minashi K. et al. A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. Jpn J Clin Oncol 2009; 39: 686-689
• 14 Yano T, Muto M, Hattori S. et al. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 2008; 40: 717-721
• 15 Hatogai K, Yano T, Kojima T. et al. Local efficacy and survival outcome of salvage endoscopic therapy for local recurrent lesions after definitive chemoradiotherapy for esophageal cancer. Radiat Oncol 2016; 11: 31
• 16 Hwang C, Youn YH, Choi SE. et al. Endoscopic Submucosal Dissection for Recurrent or Residual Superficial Esophageal Cancer after Chemoradiotherapy: Two Cases. Clin Endosc 2015; 48: 553-557
• 17 Japan Esophageal Society. Japanese classification of Esophageal Cancer. 11th Edition: part I. Esophagus 2017; 14: 1-36
• 18 Makazu M, Kato K, Takisawa H. et al. Feasibility of endoscopic mucosal resection as salvage treatment for patients with local failure after definitive chemoradiotherapy for stage IB, II, and III esophageal squamous cell cancer. Dis Esophagus 2014; 27: 42-49
• 19 Hong SN, Byeon JS, Lee BI. et al. Prediction model and risk score for perforation in patients undergoing colorectal endoscopic submucosal dissection. Gastrointest Endosc 2016; 84: 98-108
• 20 Mizushima T, Kato M, Iwanaga I. et al. Technical difficulty according to location, and risk factors for perforation, in endoscopic submucosal dissection of colorectal tumors. Surg Endosc 2015; 29: 133-139
• 21 Coia LR, Myerson RJ, Tepper JE. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 1995; 31: 1213-1236
• 22 Ishii N, Horiki N, Itoh T. et al. Endoscopic Submucosal Dissection With a Combination of Small-Caliber-Tip Transparent Hood and Flex Knife is a Safe and Effective Treatment for Superficial Esophageal Neoplasias. Surg. Endosc 2010; 24: 335-342
• 23 Koike Y, Hirasawa D, Fujita N. et al. Usefulness of the thread-traction method in esophageal endoscopic submucosal dissection: randomized controlled trial. Dig Endosc 2015; 27: 303-309
• 24 Stone HB, Coleman CN, Anscher MS. et al. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003; 4: 529-536
• 25 Goertz O, Poettgen C, Akbari A. et al. New model for long-term investigations of cutaneous microcirculatory and inflammatory changes following irradiation. J Radiat Res 2015; 56: 456-461
• 26 Tanaka S, Toyonaga T, Morita Y. Endoscopic vessel sealing: a novel endoscopic precoagulation technique for blood vessels during endoscopic submucosal dissection. Dig Endosc 2013; 25: 341-342
• 27 Nishizawa T, Tahagi N. Endoscopic mucosal resection and endoscopic submucosal dissection: technique and new directions. Curr Opin Gastroenterol 2017; 33: 315-319
• 28 Takeuchi M, Kobayashi M, Hashimoto S. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Scand J Gastroenterol 2013; 48: 1095-1101
• 29 Kumagai K, Mariosa D, Tsai JA. et al. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy. Dis Esophagus 2016; 29: 734-739
• 30 Khangura SK, Greenwald BD. Endoscopic management of esophageal cancer after definitive chemoradiotherapy. Dig Dis Sci 2013; 58: 1477-1485
• 31 Yano T, Muto M, Minashi K. et al. Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma. Endoscopy 2011; 43: 657-663
• 32 Hamada K, Ishihara R, Yamasaki Y. et al. Efficacy and Safety of Endoscopic Resection Followed by Chemoradiotherapy for Superficial Esophageal Squamous Cell Carcinoma: A Retrospective Study. Clin Transl Gastroenterol 2017; 8: 8